Package 31722-266-31

{"route": ["ORAL"], "spl_id": "3dcdfac8-4e3e-cf25-e063-6294a90a1366", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["465355"], "spl_set_id": ["fceb92c5-5269-46e2-ac5f-547b2f77953d"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (31722-266-31)  / 75 mL in 1 BOTTLE", "package_ndc": "31722-266-31", "marketing_start_date": "20250808"}], "brand_name": "Voriconazole", "product_id": "31722-266_3dcdfac8-4e3e-cf25-e063-6294a90a1366", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "31722-266", "generic_name": "Voriconazole", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Voriconazole", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "40 mg/mL"}], "application_number": "ANDA211598", "marketing_category": "ANDA", "marketing_start_date": "20250808", "listing_expiration_date": "20261231"}